The Promise of Bone Marrow Banking (Group)
Includes a Live Web Event on 07/12/2023 at 2:00 PM (EDT)
- Non-member - $100
- Member - $60
Every year, more than 9,000 people who look for a bone marrow transplant don’t find a match in time. Ossium Health is a bioengineering company that uses bone marrow from vertebral body donation to address patients’ unmet needs in hematologic malignancies, inflammatory disease and transplant rejection. As the first organization to build a bank of deceased donor bone marrow, Ossium is working to bridge the bone marrow transplant gap and ensure everyone gets the transplant they need. In this presentation, we’ll discuss how the gift of bone marrow from deceased donors can be used to save lives and share information about other therapies made possible through cells found in bone marrow.
Co-Founder and CEO
Kevin Caldwell: As CEO, Co-Founder & President of Ossium Health, Kevin Caldwell has built Ossium from a small startup into a clinical-stage bioengineering company. Kevin set the company’s mission to improve human health through bioengineering and designed its platform-based model for cellular therapeutics development. Before founding Ossium, Kevin served as an Engagement Manager at McKinsey’s San Francisco office, advising clients in the biotechnology and healthcare sectors. Mr. Caldwell led more than 20 engagements with more than a dozen clients, leading teams that advised clients on revenue growth, go-to-market strategy, and organizational restructuring. Before McKinsey, Kevin served as a Senior Investment Associate at Bridgewater Associates, where he did quantitative research for the firm’s global macro investments. A graduate of both MIT and Harvard, Mr. Caldwell studied Physics and Economics at MIT before receiving his JD from Harvard Law School. Mr. Caldwell is a member of the Young President’s Organization (YPO), and a Fellow of the Leaders in Tech Program.
Margie Mathewson, PhD
VP, Business Operations
Margie Mathewson: Dr. Mathewson’s career has focused primarily on helping start-ups, and small businesses build out robust operations, from internal structures and systems to external partnerships. Prior to joining Ossium, Dr. Mathewson was the 7th team member at Point, a FinTech start-up offering non-traditional options for home equity funding, where she led Business Operations. While there, she drove development of an underwriting process for nontraditional, complicated customers that allowed funding of Point’s initial set of homeowners, including the first to exit the investment successfully. She also worked as a consultant for McKinsey & Company, where, among other projects, she helped develop a rapid growth strategy for a successful health system and overhauled a sales and supply chain planning process. Dr. Mathewson completed her bachelor’s at the University of Illinois Urbana-Champaign and her Ph.D. at the University of California, San Diego, where she was an NSF Fellow and founded a successful mentorship program for first-generation college students in engineering.
Matt Ryll, CTBS, CEBT
Sr. Manager, Recovery Services
Matt Ryll: Matt Ryll is the Sr. Manager of Recovery Services for Ossium Health. He focuses on training and onboarding, quality and process improvements, as well as general OPO and Tissue Partner relationships. Before joining Ossium, Matt worked at New England Donor Services, where he was a Tissue Recovery Manager and a Recovery Trainer. Matt received his bachelor’s at the University of Massachusetts, Amherst, and is CTBS as well as CEBT certified.